How is Hexarelin administered?
This describes how Hexarelin is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a 1-2x daily schedule, generally over 4 weeks max. Specific dosing is individual and beyond general information, and human evidence for Hexarelin is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: 1-2x daily
- Cycle length: 4 weeks max
- Half-life: ~70 minutes
References
- Hexarelin and growth hormone secretion — Imbimbo BP et al., JCEM, 1994
- Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery — Broglio F et al., European Journal of Pharmacology, 2002
- Cardiac effects of hexarelin in hypopituitary adults — Bisi G et al., European Journal of Pharmacology, 1999
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Hexarelin
Last updated 2026-06-15.